先端医科学研究所

Medicine & Life Sciences

1. Neoplasms 100%
2. Melanoma 76%
3. Neoplastic Stem Cells 66%
4. T-Lymphocytes 64%
5. Glioma 58%
6. Melanoma-Specific Antigens 57%
7. Immunotherapy 53%
8. Tumor-Infiltrating Lymphocytes 48%
9. Neoplasm Antigens 41%
10. Stem Cells 36%
11. Antigens 33%
12. Dendritic Cells 30%
13. Cell Line 29%
14. Glioblastoma 26%
15. Genes 26%
16. HLA-A2 Antigen 25%
17. Neoplasm Metastasis 25%
18. Epitopes 24%
19. Therapeutics 23%
20. Peptides 23%
21. Proteins 20%
22. Graft vs Host Disease 20%
23. Growth 20%
24. Osteosarcoma 19%
25. Sulfasalazine 19%
26. Epithelial-Mesenchymal Transition 19%
27. Carcinogenesis 18%
28. Neural Stem Cells 17%
29. Cytotoxic T-Lymphocytes 17%
30. Brain Neoplasms 16%
31. Brain 16%
32. In Vitro Techniques 16%
33. Cholangiocarcinoma 16%
34. Melanocytes 16%
35. Optogenetics 15%
36. Phenotype 15%
37. Interleukin-2 15%
38. Stomach Neoplasms 14%
39. Antibodies 14%
40. Lacrimal Apparatus 14%
41. Idiopathic Thrombocytopenic Purpura 14%
42. Tumor Microenvironment 13%
43. Forensic Anthropology 13%
44. Vaccination 13%
45. Breast Neoplasms 13%
46. Fibroblasts 13%
47. Autoantibodies 12%
48. Down-Regulation 12%
49. HLA-A24 Antigen 12%
50. Mutation 12%
51. T-Lymphocyte Epitopes 11%
52. Cisplatin 11%
53. Non-Small Cell Lung Carcinoma 11%
54. Colonic Neoplasms 11%
55. Apoptosis 11%
56. Serum 11%
57. Epithelial Cells 11%
58. Complementary DNA 11%
59. gp100 Melanoma Antigen 11%
60. Cell Proliferation 11%
61. Reactive Oxygen Species 11%
62. Cell Movement 10%
63. Immunosuppressive Agents 10%
64. Induced Pluripotent Stem Cells 10%
65. Gene Expression 10%
66. Survival 10%
67. Cancer Vaccines 10%
68. Stomach 10%
69. Anaphase-Promoting Complex-Cyclosome 10%
70. Cell Cycle 10%
71. Systemic Scleroderma 10%
72. Phosphotransferases 10%
73. MART-1 Antigen 9%
74. Protein Isoforms 9%
75. Oxidation-Reduction 9%
76. Tumor Necrosis Factor-alpha 9%
77. Cytokines 9%
78. HLA Antigens 9%
79. Neurons 9%
80. Monophenol Monooxygenase 9%
81. Catenins 9%
82. Epithelial Cell Adhesion Molecule 9%
83. Cadherins 9%
84. Adenocarcinoma of Lung 9%
85. Clone Cells 9%
86. Oxidative Stress 9%
87. Cell Death 9%
88. Drug Therapy 8%
89. B-Lymphocytes 8%
90. Cell Survival 8%
91. Adenocarcinoma 8%
92. Astrocytes 8%
93. Pancreatic Neoplasms 8%
94. Testicular Neoplasms 8%
95. DNA Damage 8%
96. Up-Regulation 8%
97. Phosphorylation 8%
98. Messenger RNA 8%
99. Biomarkers 8%
100. Heterografts 8%